About SUPARTZ
Global Leader
SUPARTZ joint fluid therapy is the most commonly used joint fluid therapy in the world. 1 More than 119 million SUPARTZ joint fluid therapy injections have been sold worldwide since its introduction in 1987. This wealth of clinical experience provides you with the confidence that SUPARTZ joint fluid therapy, the world’s most prescribed joint fluid therapy is both safe and effective. It was also the first hyaluronan in the world available commercially for human use in treating the pain of osteoarthritis.
Safe
In the five clinical studies conducted, adverse events occurred at similar rates in the patients treated with Supartz joint fluid therapy as those treated with the saltwater placebo. The following were the most common adverse events: joint pain with no evidence of inflammation, joint pain with evidence of inflammation, back pain, pain (non-specific), injection site reaction, headache and injection site pain. No severe allergic reactions were observed in any study patients. Five (5) mild to moderate allergic reactions were reported in the SUPARTZ joint fluid therapy group. No anaphylactic reactions were observed in any study patients.
Effective
The extensive worldwide clinical history of SUPARTZ joint fluid therapy gives your doctor the confidence that SUPARTZ joint fluid therapy will safely offer you relief from your knee pain.
Active ingredient
SUPARTZ joint fluid therapy administers more active ingredient per series directly to the site of your knee pain.